Free Trial

Rigel Pharmaceuticals (RIGL) SEC Filings & 10K Form

Rigel Pharmaceuticals logo
$17.09 -0.12 (-0.70%)
(As of 12/20/2024 05:16 PM ET)

Recent Rigel Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
8:33 AM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
3:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:01 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:36 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:33 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:30 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2024
11:15 PM
Rigel Pharmaceuticals (Filer)
Form EFFECT
06/27/2024
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:45 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:19 PM
Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:05 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
7:05 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:29 PM
Rigel Pharmaceuticals (Filer)
Form ARS
04/10/2024
3:49 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/10/2024
3:50 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
4:04 PM
Rigel Pharmaceuticals (Filer)
Form PRE 14A
03/29/2024
3:09 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:14 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:15 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:15 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
6:16 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
7:00 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:30 PM
ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
11:17 AM
MORGAN STANLEY (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
02/06/2024
7:18 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:18 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:18 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
4:34 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2024
8:56 AM
Rigel Pharmaceuticals (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
01/25/2024
8:16 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
8:17 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
8:17 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

01/25/2024
8:17 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:30 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RIGL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners